Cancer Cell Adhesion

Cancer Cell Adhesion is the altered pattern of physical attachment exhibited by malignant cells, involving both a reduction in the stable cell-cell and cell-matrix connections that normally anchor cells within organized tissue and, in specific contexts, the acquisition of new or altered adhesive interactions that facilitate detachment, migration, and colonization of distant sites, together constituting a central mechanistic contributor to local invasion and metastatic spread.

Categories of Adhesion Altered in Cancer

Cell-Cell Adhesion

Adhesion structures that normally bind neighboring epithelial cells together into a cohesive tissue layer are frequently downregulated or functionally disrupted in cancer cells, weakening the physical cohesion that would otherwise restrain individual cells from separating and moving independently of the surrounding tissue.

Cell-Matrix Adhesion

Receptors that anchor cells to the surrounding extracellular matrix mediate a distinct category of adhesion, and alterations in the expression, activation state, or matrix specificity of these receptors allow cancer cells to modify their attachment behavior in ways that support migration through and invasion of new tissue compartments.

Adhesion During Circulation and Distant Colonization

A further category of adhesion becomes relevant only after cancer cells have entered the vasculature or lymphatic system, involving transient interactions with the vessel wall and, ultimately, with the extracellular matrix of a distant tissue site during the establishment of a secondary tumor.

Mechanisms of Altered Adhesion

Downregulation of Cell-Cell Adhesion Proteins

Transcriptional repression, promoter hypermethylation, or direct mutation of the genes encoding core cell-cell adhesion proteins reduces the strength and stability of intercellular junctions, a change closely associated with the epithelial-to-mesenchymal transition that accompanies invasive behavior in many carcinomas.

Altered Matrix Receptor Expression and Specificity

Cancer cells frequently shift the specific combination of matrix-binding receptors they express, favoring receptor subtypes with affinity for matrix components abundant in the tumor microenvironment or associated with a more migratory, less stationary adhesive phenotype.

Proteolytic Remodeling of Adhesive Contacts

Secretion of enzymes capable of degrading extracellular matrix components and cleaving adhesion receptors themselves allows cancer cells to actively dismantle existing adhesive structures, facilitating detachment from the primary tumor mass and subsequent passage through surrounding tissue barriers.

Dynamic Regulation of Adhesion Strength

Beyond simple loss of adhesive capacity, cancer cells often exhibit a dynamically regulated adhesive state that shifts between stronger and weaker attachment depending on local signaling context, supporting alternating phases of stable positioning and active migration rather than a uniformly reduced adhesive phenotype throughout the invasive process.

Functional Consequences

Facilitation of Local Invasion

Reduced cell-cell adhesion combined with altered matrix engagement allows individual cancer cells or small clusters to separate from the primary tumor mass and migrate into adjacent tissue compartments, representing the initial physical step in local invasive spread.

Support for Intravasation and Circulation

Altered adhesive properties assist cancer cells in traversing the vessel wall to enter the bloodstream or lymphatic circulation, and specific transient adhesive interactions with circulating blood components can additionally protect detached cancer cells from mechanical and immune stresses encountered during transit.

Establishment of Secondary Tumor Sites

Adhesive interactions with the vascular endothelium and underlying matrix at a distant site enable circulating cancer cells to arrest, extravasate, and establish physical attachment necessary for subsequent colonization and growth of a metastatic lesion.

Clinical and Therapeutic Relevance

Adhesion Markers as Prognostic Indicators

Reduced expression of core cell-cell adhesion proteins is used as a histopathological indicator of invasive potential and is associated with poorer prognosis across multiple carcinoma types, reflecting the close mechanistic link between adhesion loss and metastatic capacity.

Therapeutic Targeting of Adhesion Molecules

Strategies aimed at blocking specific matrix receptors or the enzymes responsible for adhesive remodeling seek to limit the invasive and metastatic capacity of cancer cells by directly interfering with the altered adhesive behavior that supports these processes.